Free Trial

Deutsche Bank Aktiengesellschaft Forecasts Strong Price Appreciation for Fevertree Drinks (LON:FEVR) Stock

Fevertree Drinks logo with Consumer Defensive background

Key Points

  • Deutsche Bank raised the price target for Fevertree Drinks from GBX 800 to GBX 840 while maintaining a "buy" rating, indicating a potential downside risk of 5.42% from the previous close.
  • Other analysts have varied opinions, with JPMorgan raising its target to GBX 850 and Jefferies maintaining a "hold" rating with a target of GBX 900, resulting in a consensus rating of "Hold."
  • Fevertree Drinks reported earnings of GBX 6.85 per share for the last quarter and has a current ratio of 4.11, which indicates strong liquidity.
  • MarketBeat previews the top five stocks to own by November 1st.

Fevertree Drinks (LON:FEVR - Get Free Report) had its price target upped by research analysts at Deutsche Bank Aktiengesellschaft from GBX 800 to GBX 840 in a report issued on Thursday, Marketbeat.com reports. The brokerage presently has a "buy" rating on the stock. Deutsche Bank Aktiengesellschaft's target price suggests a potential downside of 8.40% from the company's current price.

A number of other research firms have also recently weighed in on FEVR. Jefferies Financial Group restated a "hold" rating and issued a GBX 900 price target on shares of Fevertree Drinks in a report on Friday, September 12th. JPMorgan Chase & Co. increased their target price on Fevertree Drinks from GBX 770 to GBX 850 and gave the company a "neutral" rating in a report on Friday, September 12th. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of GBX 863.33.

Get Our Latest Analysis on FEVR

Fevertree Drinks Price Performance

Shares of FEVR traded up GBX 33 on Thursday, reaching GBX 917. The stock had a trading volume of 6,955,633 shares, compared to its average volume of 619,235. The firm has a market capitalization of £1.09 billion, a PE ratio of 4,398.08, a PEG ratio of -4.51 and a beta of 1.07. The company has a quick ratio of 3.21, a current ratio of 4.11 and a debt-to-equity ratio of 1.50. The firm has a 50-day moving average of GBX 891.98 and a 200 day moving average of GBX 846.83. Fevertree Drinks has a twelve month low of GBX 608.50 and a twelve month high of GBX 1,020.

Fevertree Drinks (LON:FEVR - Get Free Report) last released its quarterly earnings results on Thursday, September 11th. The company reported GBX 6.85 earnings per share for the quarter. Fevertree Drinks had a return on equity of 9.30% and a net margin of 6.05%. Sell-side analysts expect that Fevertree Drinks will post 38.3184173 EPS for the current year.

Insider Buying and Selling at Fevertree Drinks

In other Fevertree Drinks news, insider Kevin Havelock purchased 37,000 shares of Fevertree Drinks stock in a transaction on Thursday, September 11th. The shares were bought at an average price of GBX 846 per share, with a total value of £313,020. 12.57% of the stock is currently owned by corporate insiders.

About Fevertree Drinks

(Get Free Report)

Fevertree Drinks PLC, together with its subsidiaries, engages in the development and sale of premium mixer drinks in the United Kingdom, the United States, rest of Europe, and internationally. It offers Indian, Mediterranean, summer garden, elderflower, cucumber, damson and sloe berry, rhubarb and raspberry, aromatic, lemon, and Clementine tonic water products; pink grapefruit, soda water, raspberry and orange blossom, Mexican lime, Italian blood orange, white grape and apricot sodas; Silician, premium, and Madagascan cola and lemonades; British apple with garden mint, ginger, Sicilian lemonade, sparkling Mexican lime, Italian white grape and apricot, and light raspberry and rose lemonade softdrinks; and gingers.

See Also

Should You Invest $1,000 in Fevertree Drinks Right Now?

Before you consider Fevertree Drinks, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fevertree Drinks wasn't on the list.

While Fevertree Drinks currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.